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Summary
 
We have developed a stroma-free culture system in which mouse marrow or thymus cells,
known to be enriched for lymphoid progenitors, can be driven to generate natural killer (NK)
cells. Culture of lineage marker (Lin)
 
2
 
, c-kit
 
1
 
, Sca2
 
1
 
, interleukin (IL)-2/15R
 
b
 
 (CD122)
 
2
 
marrow cells in IL-6, IL-7, stem cell factor (SCF), and flt3 ligand (flt3-L) for 5–6 d followed by
IL-15 alone for an additional 4–5 d expanded the starting population 30–40-fold and gave rise
to a virtually pure population of NK1.1
 
1
 
, CD3
 
2
 
 cells. Preculture in IL-6, IL-7, SCF, and flt3-L
was necessary for inducing IL-15 responsiveness in the progenitors because the cells failed to
significantly expand when cultured in IL-15 alone from the outset. Although culture of the
sorted progenitors in IL-6, IL-7, SCF, and flt3-L for the entire 9–11-d culture period caused
significant expansion, no lytic NK1.1
 
1
 
 cells were generated if IL-15 was not added, demon-
strating a critical role for IL-15 in NK differentiation. Thus, two distinct populations of NK
progenitors, IL-15 unresponsive and IL-15 responsive, have been defined. Similar results were
obtained with Lin
 
2
 
, CD44
 
1
 
, CD25
 
2
 
, c-kit
 
1
 
 lymphoid progenitors obtained from adult thy-
mus. The NK cells generated by this protocol lysed the NK-sensitive target YAC-1 and ex-
pressed markers of mature NK cells with the notable absence of Ly-49 major histocompatibility
complex (MHC) receptors. However, despite the apparent lack of these inhibitory MHC re-
ceptors, the NK cells generated could distinguish MHC class I
 
1
 
 from class I
 
2
 
 syngeneic targets,
suggesting the existence of novel class I receptors.
 
N
 
K cells express two families of receptors, which in the
murine system are known as NKR-P1 and Ly-49 (1).
The NKR-P1 molecule is expressed on all NK cells of cer-
tain mouse strains and may play a role in triggering NK cy-
totoxicity. Conversely, the Ly-49 receptors, which recog-
nize class I MHC molecules, are expressed on subsets of
NK cells and inhibit NK-mediated lysis.
Despite increasing knowledge of NK cell function and
target cell recognition, differentiation of NK cells from he-
matopoietic stem cells is poorly understood. NK cells are
known to be bone marrow derived, and early work sug-
gested an important role for the marrow microenviron-
ment in generating mature lytic NK cells (2). To dissect the
steps of NK differentiation, several in vitro systems have
been established that allow the development of lytic NK cells
from CD34
 
1
 
 human cells (3–6) or unseparated rodent bone
marrow (reviewed in reference 7). However, in many of
these systems, the starting populations were heterogeneous,
containing pluripotent stem cells and progenitors at differ-
ent stages of development. In addition, the NK cells that
developed were not fully characterized, especially with re-
spect to the expression and function of class I MHC recep-
tors.
Although IL-2 has frequently been used to support NK
development, the failure to detect the IL-2 gene product
within bone marrow stroma (8) and the presence of NK cells
in IL-2
 
2
 
/
 
2
 
 mice (9) strongly suggests that cytokines other than
IL-2 participate in NK cell differentiation in vivo. The
newly described cytokine IL-15 has been shown to use
both the common 
 
g
 
 chain (
 
g
 
c) and IL-2R
 
b
 
 as components
of its receptor (10), and it is produced by bone marrow
stromal cell cultures (8). In addition, IL-15 supports devel-
opment of NK cells from human CD34
 
1
 
 stem cells and
murine fetal thymic cells (8, 11) and causes terminal differ-
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entiation of immature, nonlytic NK1.1
 
1
 
 cells found in the
spleen of marrow ablated mice (12).
In the present report, we describe an in vitro culture sys-
tem yielding virtually pure populations of lytic NK1.1
 
1
 
 cells
from lineage (Lin)
 
2
 
, c-kit
 
1
 
, and Sca2
 
1
 
 multipotent pro-
genitors in the absence of stroma. The data show that a
mixture of early acting cytokines and IL-15 play sequential
and important roles in the differentiation of NK cells from
these marrow progenitors.
 
Materials and Methods
 
Animals.
 
7–12-wk C57BL/6 mice were bred at The Univer-
sity of Texas Southwestern Medical Center (Dallas, TX) and used
for bone marrow progenitor experiments. 4–5-wk (C57BL/6 
 
3
 
BALB/C)F1 mice (Jackson Labs., Bar Harbor, ME) were used for
thymic progenitor experiments.
 
mAbs.
 
Except as noted below, all mAbs and their isotype
controls were obtained from PharMingen (San Diego, CA). Anti-
gp49B1 FITC (B23.1) was the gift of Dr. H. Katz (Harvard Univer-
sity, Boston, MA), anti-Ly-49G2 (4D11) and anti-Ly-49D (12A8)
were provided by Dr. J. Ortaldo (National Cancer Institute, Fred-
erick, MD), anti-Ly-49A (JR9-318) was the gift of Dr. J. Roland
(Institut Pasteur, Paris, France), and anti-Sca2 hybridoma superna-
tant was provided by Dr. G. Spangrude (University of Utah, Salt
Lake City, UT). Goat anti–rat 
 
g
 
 Texas red (Southern Biotechnol-
ogy Assoc., Birmingham, AL) or streptavidin-Red670 (GIBCO
BRL, Gaithersburg, MD) was used to detect some primary anti-
bodies.
 
Cell Preparation, Isolation, and Analysis of Precursor Cells.
 
Cell
suspensions of bone marrow and thymocytes were prepared as
previously described (13, 14). Staining was performed on ice in
PBS/5 mM EDTA at 3 
 
3
 
 10
 
6
 
 cells/ml. For three-color sorting
of bone marrow progenitors, cells were incubated with anti-
Fc
 
g
 
RIII/II (2.4G2) and then with a mixture of lineage-specific
biotinylated antibodies: anti-B220 (RA3-6B2), anti-CD2 (RM2-5),
anti-Gr1 (RB6-8C5), anti-CD11b (M1/70), and anti-NK1.1
(PK136) followed by streptavidin magnetic beads (Miltenyi Bio-
tec Inc., Auburn, CA). After washing, the cells were passed over a
CS column (Miltenyi Biotec Inc.) to remove Lin
 
1
 
 cells. The Lin-
depleted population was then stained with streptavidin-Red670,
c-kit (2B8) PE, and Sca2 (thymic shared antigen [TSA]1) FITC. Lin-
Red670
 
2
 
, c-kit PE
 
1
 
, Sca2 FITC
 
1
 
 cells of lymphoid and blast size
were then sorted on a FACStar Plus
 
Ò
 
 flow cytometer (Becton
Dickinson, San Jose, CA) using Lysis II software. The identifica-
tion and isolation of CD4
 
lo
 
 (CD44
 
1
 
, CD25
 
2
 
, c-kit
 
1
 
, Lin
 
2
 
) has
been previously described (14).
For four-color analysis of marrow progenitors, cells were stained
sequentially with anti-Sca2 hybridoma supernatant, goat anti–rat 
 
g
 
Texas red, 10% normal rat serum, the cocktail of biotinylated
Lin-specific mAbs described above, and finally a mixture of strep-
tavidin-Red670, c-kit FITC, or PE and either CD44 (IM7) PE,
IL-2/15R
 
b
 
 (TM-
 
b
 
1) PE, HSA (M1/69) FITC, or CD4 (H129.19)
FITC. Analysis of cultured cells was performed by sequential stain-
ing with 2.4G2, a biotinylated mAb, and finally streptavidin-
Red670 plus an FITC- and/or PE-conjugated mAb.
 
Culture Conditions.
 
Sorted Lin
 
2
 
, c-kit
 
1
 
, Sca2
 
1
 
 marrow cells
were cultured in 96-well U-bottomed plates (Falcon, San Jose, CA)
at 8,000–10,000 cells/well in 0.2 ml of complete RPMI-1640
(10% FBS, 100 U/ml streptomycin, 1 mM sodium pyruvate, 2 mM
glutamine, 1
 
3
 
 nonessential amino acids, 50 
 
m
 
g/ml gentamicin, 5 
 
3
 
10
 
2
 
5
 
 M 2-mercaptoethanol, and 1 
 
m
 
g/ml Indomethacin) plus 20
ng/ml murine IL-15 (a gift from Dr. Tony Trout, Immunex
R&D Corp., Seattle, WA) or a mixture of 20 ng/ml murine IL-6
(PharMingen), 0.5 ng/ml murine IL-7 (PeproTech, Rocky Hill,
NJ), 50 ng/ml rat stem cell factor (SCF; a gift from Amgen,
Thousand Oaks, CA), and 100 U/ml murine flt3 ligand (flt3-L;
DNAX, Palo Alto, CA). The cells were refed with the same me-
dia on day 3, and then on day 5 or 6 the cultures were harvested,
washed, counted, and replated at 10,000–15,000/well in com-
plete RPMI containing IL-15 alone or the mixture of cytokines
described above. After an additional 3 d, the cultures were refed
with the same media, and on day 11 or 12 of total culture time,
the cells were harvested for analysis. Sorted Lin
 
2
 
, CD44
 
1
 
,
CD25
 
2
 
, c-kit
 
1
 
 thymic progenitors were cultured as previously
described (15), and the two-step culture protocol described above
for marrow progenitors was followed.
 
Target Cells and Cytotoxicity Assays.
 
Tumor targets used were
YAC-1 (H-2
 
a
 
); RMA (H-2
 
b
 
); a transport associated with antigen
processing (Tap)-2 mutant derivative of RMA, RMA-S (H-2
 
b
 
);
and a Tap-2 transfectant of RMA-S, Q11 (H-2
 
b
 
; reference 16),
which was a kind gift of Dr. J. Monaco (University of Cincinnati,
Cincinnati, OH). All cell lines were maintained in supplemented
RPMI-1640 (17); Q11 additionally received 1 mg/ml G418.
Target cells were used in a 4-h 
 
51
 
Cr cytotoxicity assay, and per-
cent specific lysis was expressed as the mean 
 
6
 
 SEM of triplicate
wells and calculated as described earlier (17).
 
RNA Extraction, PCR Amplification, and Southern Analysis.
 
Total RNA was prepared from whole cells using a modification
of the Chomczynski and Sacchi method. Reverse transcription
was performed using the Superscript II system (GIBCO BRL)
and PCR using the GIBCO BRL PCR kit with standard PCR
buffer (1.5 mM MgCl
 
2
 
) for 35 cycles (94
 
8
 
C for 30 s, 55
 
8
 
C for 30 s,
72
 
8
 
C for 1 min). Primers were designed from the published IL-
15R
 
a
 
 sequence (18). Under these conditions, the forward primer
(CTCCAGGCTGACACCATC) and reverse primer (CATGGTT-
TCCACCTCAACACGGCA) yield a 282-bp product. PCR
products were transferred to Hybond N plus (Amersham Life Sci-
ence Corp., Arlington Heights, IL) and probed with an end-labeled
internal IL-15R
 
a
 
 oligo (GAGAACGTCGTTGTTACTG) at
55
 
8
 
C. IL-2–cultured NK cells served as a positive control for
IL-15R
 
a
 
 message, and RNA integrity was confirmed by amplifi-
cation of glyceraldehyde-3-phosphate-dehydrogenase (GAPDH).
 
Results and Discussion
 
Isolation and Characterization of a Lin
 
2
 
, c-kit
 
1
 
, Sca2
 
1
 
 Bone
Marrow Population.
 
We previously identified a multipo-
tential bone marrow population characterized as Ly6 (Sca1)
 
1
 
,
Lin
 
2
 
, c-kit (CD117)
 
1
 
, CD43
 
hi
 
, Fall-3
 
hi
 
, Sca2 (TSA1)
 
2
 
,
AA4
 
lo
 
, and Rh123
 
hi
 
 with both lymphoid and myeloid re-
populating abilities in vivo (13). Upon adoptive transfer,
this population also gives rise to NK cells (13). To define a
population capable of giving rise to NK cells in vitro, a
marker more restricted to the lymphoid lineage was sought.
TSA-1, also known as Sca2 (19), was previously found to
delineate a population of Lin
 
2
 
, Thy-1
 
lo
 
, HSA (CD24)
 
1
 
 bone
marrow cells enriched for lymphoid (T and B cell) repopu-
lating ability, but essentially devoid of pluripotent stem cells
(20). Because NK cells may share a common progenitor with
T and B cells (21) and may indeed derive from an NK/T
precursor (11, 22), we hypothesized that a marrow popula-
tion expressing Sca2 may also contain NK progenitors. Thus, 
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a Lin (CD2, B220, Gr1, CD11b, NK1.1)
 
2
 
, c-kit
 
1
 
, Sca2
 
1
 
population, representing 
 
z
 
1% of whole bone marrow, was
isolated. Four-color analysis revealed that these cells were
CD44
 
hi
 
, HSA
 
int
 
, and CD4
 
2
 
 (data not shown). The pheno-
type of this population is similar to a CD4
 
lo
 
, CD82, CD32,
CD441, Sca21, c-kit1, CD252 lymphoid progenitor from
thymus (23) and to a related CD42/lo, Lin2, Thy1lo, HSAint,
CD44hi, and Sca21 population isolated from bone marrow
with predominant lymphoid and limited myeloid repopu-
lating abilities (20).
Culture of Lin2, c-kit1, Sca21 Multipotent Progenitors. To
determine the ability of this “lymphoid-enriched” progeni-
tor population to give rise to NK cells, sorted Lin2, c-kit1,
Sca21 cells were cultured with IL-15 for 9–11 d. However,
these cells failed to expand significantly in IL-15 alone (Ta-
ble 1). Cell recovery on average (n 5 6) was only 1.8-fold
over the input numbers of cells, but these cells did lyse the
NK-sensitive tumor YAC-1 (Fig. 1). It is possible that a
small number of the progenitors are truly capable of re-
sponding to IL-15 alone. We do not favor this hypothesis
because cell surface expression of IL-2/15Rb was not de-
tected on the sorted population (Fig. 2 B), and the b chain
is usually required for signal transduction (24). Alterna-
tively, this growth may represent contamination by rare
mature NK cells.
Although the sorted marrow progenitor cells failed to
expand significantly when cultured in IL-15 only, when
cultured for 5–6 d in IL-6, IL-7, SCF, and flt3-L and then
placed in IL-15 alone for an additional 4–5 d, significant
expansion occurred (Table 1), and the majority of cells gen-
erated were NK1.11 and lytic (Table 1 and Fig. 1). If the
cultures were maintained in the original cocktail instead of
switching to IL-15, significant expansion again occurred, but
no lytic activity and few, if any, NK1.11 cells were detect-
able. Together these data indicate that culture of sorted
Lin2, c-kit1, Sca21 progenitors in the early acting cyto-
kines causes expansion and primes at least some cells within
this population to respond to IL-15 alone. The identity of
other cells generated in the presence of the cytokine cock-
tail and absence of IL-15 is still being explored, but a small
fraction (z13%) are CD191, sIgM2, indicative of imma-
ture B cells, whereas a larger fraction (z63%) express high
levels of CD11b. Thus, it appears that this population may
be multipotential. The data also point to a critical role for
IL-15 in NK differentiation because culture of the multi-
potential progenitors, “primed” by early cytokines in IL-15
only, generated a population of predominantly NK1.11 cells.
Table 1. Expansion and Generation of NK Cells from Lin2, 
c-kit1, Sca21 Bone Marrow Progenitors Cultured in IL-6, IL-7, 
SCF, and flt3-L 6 IL-15
Primary culture Secondary culture
Total
Yield‡ NK1.11 Cytokines Yield* Cytokines Yield*
%
IL-15 0.3 IL-15 1.0 0.3 ND
6/7/SCF/flt3-L 9.4 6/7/SCF/flt3-L 8.7 81.8 2
6/7/SCF/flt3-L 9.4 IL-15 3.8 35.7 85
Sorted progenitors were cultured in the two-part culture system as de-
scribed in Materials and Methods. NK1.1 expression was assessed using
PE-labeled anti-NK1.1 mAb (PK136) from PharMingen. The data are
representative of six experiments.
*Yield represents the fold increase in total cell number.
‡Total yield is the product of the yield in the primary and secondary
cultures.
Figure 1. Lytic activity of Lin2, c-kit1, Sca21 cells cultured with a
cocktail of early acting cytokines 6 IL-15. Sorted cells were cultured in
the indicated cytokines as described in Materials and Methods. Cytotoxic
activity was assessed on YAC-1 tumor cells. The data are representative of
six experiments.
Figure 2. Expression of IL-
15Ra messenger RNA and IL-2/
15Rb on Lin2, c-kit1, Sca21 pro-
genitors and an IL-15–responsive
population derived by culture of
the progenitors in IL-6, IL-7, SCF,
and flt3-L. (A) IL-15Ra message
levels were determined with RNA
isolated from sorted Lin2, c-kit1,
Sca21 progenitors in two experi-
ments (lanes 1 and 2) and from a
population of splenic NK cells (45%
NK1.11 by flow cytometry) de-
rived by culture of spleen cells in
500 U/ml of recombinant human
IL-2 for 4 d (lane 3). (B) IL-2/
15Rb expression was examined by
flow cytometry on gated Lin2,
c-kit1, Sca21 cells using PE-labeled
anti–IL-2/15Rb mAb TM-b1.
The data are representative of three
experiments. (C) Sorted Lin2,
c-kit1, Sca21 cells, cultured for 5 d
in IL-6, IL-7, SCF, and flt3-L,
were stained for IL-2/15Rb ex-
pression using FITC-labeled TM-
b1. Shaded curves represent stain-
ing with TM-b1, whereas open
curves represent staining with iso-
type control mAbs. The data are
representative of two experiments.1612 Generation of Murine NK Cells In Vitro from Multipotent Progenitors
Similar experiments were performed using immature thy-
mic progenitors (Lin2, CD441, CD252, c-kit1, CD4lo) pre-
viously shown to generate T, B, and NK cells (14, 23). When
these cells were cultured with IL-15 alone, all cells died
within 72 h (Table 2). However, like the marrow progeni-
tor population, when this thymic population was cultured
in a cocktail of early acting cytokines and then switched to
culture with IL-15 only, significant expansion was observed
and a virtually pure population of NK1.11 cells was gener-
ated. In initial experiments, the primary culture was per-
formed in IL-3, IL-6, IL-7, and SCF because this mixture
is known to maintain and expand lymphoid progenitors
(14). Because IL-3 is a T cell–derived cytokine that should
not be required for NK differentiation, we hypothesized
that the NK progenitors would develop in the absence of
IL-3. Indeed, culture in IL-6, IL-7, IL-15, SCF, and flt3-L
for 13 d generated large numbers of an 86% pure popula-
tion of NK cells, whereas culture in the absence of IL-15
failed to give rise to NK1.11 cells but did result in signifi-
cant expansion (Table 2).
Expression of IL-15Ra and IL-2/15Rb by Sorted Popula-
tion and Developmental Intermediates. The ability of IL-6,
IL-7, SCF, and flt3-L to induce IL-15 responsiveness in
sorted Lin2, c-kit1, Sca21 cells suggested that this mixture
of cytokines may be inducing expression of functional IL-15
receptors. Sorted Lin2, c-kit1, Sca21 bone marrow cells were
thus examined for IL-15Ra expression by PCR and IL-2/
15Rb expression by FACSÒ analysis. Interestingly, the freshly
sorted cells did express transcripts of IL-15Ra (Fig. 2 A),
but they failed to show cell surface expression of IL-2/
15Rb (Fig. 2 B). Furthermore, preliminary evidence has
indicated surface expression of the gc by a small proportion
of these cells (data not shown). These data suggest that the
failure of sorted Lin2, c-kit1, Sca21 cells to expand signifi-
cantly in IL-15 alone is most likely due to the absence of
IL-2/15Rb expression. We, therefore, anticipated that cul-
ture of Lin2, c-kit1, Sca21 cells in IL-6, IL-7, SCF, and
flt3-L would induce IL-2/15Rb expression. Indeed, after
primary culture, z13% of the progenitors expressed IL-2/
15Rb (Fig. 2 C), but not NK1.1 (data not shown). Upon
further culture in IL-15, the vast majority of the NK1.11
cells generated also expressed IL-2/15Rb (data not shown).
These data thus suggest that IL-2/15Rb expression may pre-
cede that of NK1.1, and its acquisition may be a critical
event in NK cell differentiation. This idea is supported by
the absence of NK cells in IL-2/15Rb2/2 mice (25) and
isolation of an IL-2/15Rb1, NK1.12 population from SCID
bone marrow that can give rise to lytic NK1.11 cells upon
culture in IL-15 (our unpublished data).
Cell Surface Profile of In Vitro Generated NK Cells. The NK
cells generated by culture of marrow progenitor cells were
Table 2. Expansion and Generation of NK Cells from Lin2, CD441, CD252, c-kit1 Thymic Progenitors Cultured in IL-3 or flt3-L and 
IL-6, IL-7, and SCF 6 IL-15
Primary culture (6–7 d) Secondary culture (6–7 d)
Total
Yield Cytokines Yield Cytokines Yield % NK1.11
IL-15 0
3/6/7-SCF 10.4 IL-15 5.8 60.3 93
6/7/SCF/flt3-L ND 6/7/SCF/flt3-L – 40* 1.8
6/7/15/SCF/flt3-L ND 6/7/15/SCF/flt3-L – 381* 86
Sorted Lin2, CD441, CD252, c-kit1 thymic progenitors were cultured for the indicated number of days and analyzed as described in Table 1.
*In these experiments, only the total yield was determined after the secondary culture.
Figure 3. Ly-49 profile of NK cells generated from culture of Lin2,
c-kit1, Sca21 progenitors. Expression of NK1.1 was analyzed by setting a
“live” gate based on forward and side scatter of the cells, whereas expres-
sion of the remainder of the markers was analyzed on NK1.11, live cells.
Shaded curves represent staining with the NK1.1 or Ly49 mAbs, whereas
open curves represent staining with isotype control mAbs. The data are
representative of four separate experiments.1613 Williams et al. Brief Definitive Report
phenotypically quite similar to mature IL-2–activated
splenic NK cells (12, 26, 27). They were CD32, CD11b1,
FcgRIII/II1, IL-2/15Rb1, c-kit2, and 2B41 (data not
shown) and lysed the NK-sensitive target YAC-1 (Fig. 1).
Interestingly, they also expressed gp49B1, an inhibitory re-
ceptor of the Ig superfamily shared by mast cells (28). How-
ever, they failed to express the Ly-49 family of MHC re-
ceptors (Fig. 3). In four experiments, expression of Ly-49A,
C/I, and D was undetectable or ,3% over isotype con-
trols, whereas mature C57BL/6 splenic NK1.11 cells are
20% Ly-49A1, 50% Ly-49C/I1, and 50% Ly-49D1. Ex-
pression of Ly-49G2 was slightly more variable ranging from
2–8% over isotype controls, whereas nearly 50% of splenic
NK cells express this receptor. We have been unable to as-
certain whether the in vitro–derived NK cells truly express
low levels of Ly-49G2 or whether this antibody simply shows
nonspecific binding. In any case, these data suggest that NK
cells acquire expression of NK1.1 before expression of Ly-
49 receptors. The factors required for induction of Ly-49
molecules are unknown, but it is clear that IL-15 alone is
not sufficient.
Cytotoxic Activity of In Vitro–generated NK Cells Against
Class I1 and Class I2 Tumor cells. It has been demon-
strated that interaction of Ly-49 receptors with their appro-
priate MHC class I ligands sends an inhibitory signal to NK
cells and prevents NK-mediated lysis of the class I1 target
(1). However, despite the failure to express significant lev-
els of Ly-49 MHC receptors, these in vitro–derived NK
cells differentiated class I1 from class I2 syngeneic tumor
cells. They lysed class Ilo Tap-deficient RMA-S cells but
failed to lyse RMA, the class I1 parent of RMA-S (Fig. 4).
That this difference in lysis was due to the absence of class I
on the surface of RMA-S is supported by the observation
that the culture-derived NK cells failed to lyse Q11, a class
I1 Tap-2 transfectant of RMA-S (16).
In summary, we have developed a stroma-free culture
system capable of generating lytic NK1.11 cells from a de-
fined multipotential progenitor population contained in the
bone marrow. This system has allowed identification of a
putative (NK1.12) developmental intermediate in NK dif-
ferentiation, characterized by expression of IL-2/15Rb and
the ability to respond to IL-15. One or all of a mixture of
cytokines including IL-6, IL-7, SCF, and flt3-L was shown
to be critical in reaching this developmental stage. This
study also provided additional evidence for the critical role
that IL-15 plays in NK differentiation, because no NK1.11
cells were detected in its absence. IL-15 was not, however,
capable of inducing expression of the Ly-49 family of MHC
molecules, suggesting that some stimulus necessary to in-
duce Ly-49 expression was missing from this culture sys-
tem. Finally, these data suggested that development of lytic
activity and expression of NK1.1 can precede expression of
Ly-49 molecules; however, despite the absence of these re-
ceptors, the in vitro–derived NK cells could distinguish
class I1 from class I2 syngeneic tumor cells, suggesting the
existence of novel class I receptors.
Figure 4. Lysis of syngeneic Tap1/1 and Tap2/2 tumor cells by in vitro
generated NK cells. Target cells were class I1 RMA (Tap1/1) and Q11
(Tap1/1) and class Ilo RMA-S (Tap2/2). The data are representative of
three separate experiments.
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